1 unchanged sentence
Insider Trading Arrangements
−Removed: The following is a summary of the material terms of the contracts, instructions or written plans for the purchase or sale of the Company’s securities adopted or terminated by our officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) and directors during the quarter ended March 31, 2024:
+Added: The following is a summary of the material terms of the contracts, instructions or written plans for the purchase or sale of the Company’s securities adopted or terminated by our officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) and directors during the quarter ended June 30, 2024:
Type of Trading Arrangement
Name and Position Date Action Rule 10b5-1* Expiration Date Total Ordinary Shares to be Sold
−Removed: Robert Iannone March 7, 2024 Modification X March 7, 2025 10,681
−Removed: Executive Vice President, Global Head of Research and Development
+Added: Bruce Cozadd June 5, 2024 Adoption X October 31, 2025 114,500
+Added: Chairman and Chief Executive Officer
* Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
4 unchanged sentences
001-33500) for the period ended June 30, 2016, as filed with the SEC on August 9, 2016).
−Removed: 4.1 Reference is made to Exhibit 3.1.
−Removed: 4.2 Indenture, dated as of April 29, 2021, among Jazz Securities Designated Activity Company, the guarantors party thereto, U.S.
−Removed: Bank National Association, as trustee and acknowledged by U.S.
−Removed: Bank National Association, as collateral trustee.
−Removed: (incorporated herein by reference to Exhibit 4.1 in Jazz Pharmaceuticals plc’s Current Report on Form 8-K (File No.
−Removed: 001-033500), as filed with the SEC on April 29, 2021).
+Added: 10.1 Amendment No.
+Added: 2, dated as of July 19, 2024, by and among Jazz Pharmaceuticals Public Limited Company the other borrowers from time to time party thereto, the lenders and issuing banks from time to time party thereto, Bank of America, N.A., as administrative agent, and U.S.
+Added: Bank Trust Company, National Association, as collateral trustee (incorporated by reference to Exhibit 10.1 in Jazz Pharmaceuticals plc’s Current Report on Form 8-K (File No.
+Added: 001-033500), as filed with the SEC on July 22, 2024).
10.2+ Offer Letter from Jazz Pharmaceuticals, Inc.
−Removed: to Philip Johnson dated as of January 30, 2024.
−Removed: 10.2+ Amended and Restated Non-Employee Director Compensation Policy (approved April 25, 2024).
+Added: to Samantha Pearce .
31.1 Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
3 unchanged sentences
101.INS XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
−Removed: 101.SCH Inline XBRL Taxonomy Extension Schema Document
−Removed: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: 101.LAB Inline XBRL Taxonomy Extension Labels Linkbase Document
−Removed: 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: 101.SCH Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
__________________
+Added: + Indicates management contract or compensatory plan.
‡ Certain portions of this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K.
2 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: August 1, 2024
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
9 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.